| scholarly article | Q13442814 |
| P50 | author | German Bou | Q42555605 |
| P2093 | author name string | Marina Oviaño | |
| P2860 | cites work | Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics | Q24623358 |
| Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications | Q24646677 | ||
| Laboratory automation in clinical bacteriology: what system to choose? | Q26775079 | ||
| MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis | Q26795481 | ||
| Microbial typing by matrix-assisted laser desorption ionization-time of flight mass spectrometry: do we need guidance for data interpretation? | Q26858991 | ||
| Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study | Q28005554 | ||
| Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship | Q28068503 | ||
| Evaluation of the Xpert Carba-R (Cepheid) Assay Using Contrived Bronchial Specimens from Patients with Suspicion of Ventilator-Associated Pneumonia for the Detection of Prevalent Carbapenemases | Q28354047 | ||
| Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry | Q29616600 | ||
| Identification of Staphylococcus aureus and determination of its methicillin resistance by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | Q30755631 | ||
| Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry | Q30844573 | ||
| Experimental factors affecting the quality and reproducibility of MALDI TOF mass spectra obtained from whole bacteria cells | Q30914209 | ||
| Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia | Q31125537 | ||
| Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry | Q32156181 | ||
| Reproducibility in protein profiling by MALDI-TOF mass spectrometry | Q33280555 | ||
| MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole | Q33502781 | ||
| Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry. | Q33555783 | ||
| OXA-type beta-lactamases | Q33762371 | ||
| The reactivity of beta-lactams, the mechanism of catalysis and the inhibition of beta-lactamases | Q33762382 | ||
| Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast | Q33804812 | ||
| Differentiation of cfiA-negative and cfiA-positive Bacteroides fragilis isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q33827809 | ||
| Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system | Q33890222 | ||
| Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. | Q33901939 | ||
| Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry | Q33934938 | ||
| Evaluation of the analytical performance of the Xpert MTB/RIF assay. | Q33963553 | ||
| Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q33966781 | ||
| Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. | Q33973352 | ||
| A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae | Q34058562 | ||
| Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q34168334 | ||
| Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species | Q34246802 | ||
| Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q34254372 | ||
| Clinical microbiology informatics. | Q34297646 | ||
| Emerging technologies for the clinical microbiology laboratory. | Q34297668 | ||
| Identical MALDI TOF MS-derived peak profiles in a pair of isogenic SCCmec-harboring and SCCmec-lacking strains of Staphylococcus aureus | Q34323196 | ||
| Aminoglycoside modifying enzymes | Q34354185 | ||
| Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. | Q34522207 | ||
| The presence of a single MALDI-TOF mass spectral peak predicts methicillin resistance in staphylococci | Q34538664 | ||
| Matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis | Q34538888 | ||
| Comparison of the accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry with that of other commercial identification systems for identifying Staphylococcus saprophyticus in urine | Q34579823 | ||
| Characterization of Staphylococcus aureus isolated from clinical specimens by matrix assisted laser desorption/ionization time-of-flight mass spectrometry | Q34788700 | ||
| Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis | Q34793588 | ||
| Plasmid-mediated quinolone resistance | Q34888920 | ||
| MALDI biotyper-based rapid resistance detection by stable-isotope labeling | Q34978453 | ||
| Direct identification of pathogens from positive blood cultures using matrix-assisted laser desorption-ionization time-of-flight mass spectrometry. | Q35044260 | ||
| Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures | Q35084748 | ||
| Identification of CMY-2-type cephalosporinases in clinical isolates of Enterobacteriaceae by MALDI-TOF MS | Q35102361 | ||
| Insufficient discriminatory power of MALDI-TOF mass spectrometry for typing of Enterococcus faecium and Staphylococcus aureus isolates | Q35116028 | ||
| Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. | Q35166033 | ||
| Rapid detection of enterobacteriaceae producing extended spectrum beta-lactamases directly from positive blood cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry. | Q35190606 | ||
| Identification of agr-positive methicillin-resistant Staphylococcus aureus harbouring the class A mec complex by MALDI-TOF mass spectrometry | Q35223590 | ||
| Quantitative matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid resistance detection | Q35260384 | ||
| Matrix-assisted laser desorption ionization-time of flight mass spectrometry meropenem hydrolysis assay with NH4HCO3, a reliable tool for direct detection of carbapenemase activity. | Q35455133 | ||
| Matrix-assisted laser desorption ionization-time of flight mass spectrometry identifies Pseudomonas aeruginosa high-risk clones | Q35555612 | ||
| Blood culture-based diagnosis of bacteraemia: state of the art. | Q35573982 | ||
| Matrix-assisted laser desorption/ionization time of flight mass-spectrometry (MALDI-TOF MS) based typing of extended-spectrum β-lactamase producing E. coli--a novel tool for real-time outbreak investigation | Q35599233 | ||
| Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Less Than 30 Minutes | Q35618481 | ||
| Cost Savings Realized by Implementation of Routine Microbiological Identification by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry | Q35637199 | ||
| MALDI-TOF MS as a Tool To Detect a Nosocomial Outbreak of Extended-Spectrum-β-Lactamase- and ArmA Methyltransferase-Producing Enterobacter cloacae Clinical Isolates in Algeria | Q35736641 | ||
| Rapid detection of porins by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. | Q35753432 | ||
| Clinical Performance of a Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method for Detection of Certain blaKPC-Containing Plasmids | Q35764330 | ||
| A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory | Q35867084 | ||
| Rapid Detection of KPC, NDM, and OXA-48-Like Carbapenemases by Real-Time PCR from Rectal Swab Surveillance Samples | Q35868677 | ||
| Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures | Q36030539 | ||
| Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. | Q36047378 | ||
| Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of KPC-Producing Klebsiella pneumoniae | Q36076941 | ||
| Rapid detection of AAC(6')-Ib-cr production using a MALDI-TOF MS strategy | Q36112167 | ||
| Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial. | Q36115424 | ||
| Evaluation of a Semiquantitative Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method for Rapid Antimicrobial Susceptibility Testing of Positive Blood Cultures | Q36133412 | ||
| Molecular Imaging of Growth, Metabolism, and Antibiotic Inhibition in Bacterial Colonies by Laser Ablation Electrospray Ionization Mass Spectrometry | Q36152888 | ||
| New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group | Q36174064 | ||
| Universal protocol for the rapid automated detection of carbapenem-resistant Gram-negative bacilli directly from blood cultures by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS). | Q36190401 | ||
| Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Combined Species Identification and Drug Sensitivity Testing in Mycobacteria. | Q36230810 | ||
| Can MALDI-TOF Mass Spectrometry Reasonably Type Bacteria? | Q36250918 | ||
| Effect of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Alone versus MALDI-TOF MS Combined with Real-Time Antimicrobial Stewardship Interventions on Time to Optimal Antimicrobial Therapy in Patients with | Q36287903 | ||
| The use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid bacterial identification in patients with smear-positive bacterial meningitis | Q36377253 | ||
| Detection of SPM-1-producing Pseudomonas aeruginosa and class D β-lactamase-producing Acinetobacter baumannii isolates by use of liquid chromatography-mass spectrometry and matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q36506376 | ||
| Evaluation of the BYG Carba Test, a New Electrochemical Assay for Rapid Laboratory Detection of Carbapenemase-Producing Enterobacteriaceae. | Q36521302 | ||
| An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases | Q36727850 | ||
| Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. | Q37058913 | ||
| Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. | Q37263566 | ||
| Rapid Identification of OXA-48 and OXA-163 Subfamilies in Carbapenem-Resistant Gram-Negative Bacilli with a Novel Immunochromatographic Lateral Flow Assay. | Q37363447 | ||
| Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae | Q37544774 | ||
| Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations. | Q37962081 | ||
| OXA-48-like carbapenemases: the phantom menace | Q38002399 | ||
| Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs | Q38073195 | ||
| The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide | Q38220361 | ||
| Clinical Chemistry Laboratory Automation in the 21st Century - Amat Victoria curam (Victory loves careful preparation). | Q38261903 | ||
| The role of OXA-1 beta-lactamase Asp(66) in the stabilization of the active-site carbamate group and in substrate turnover | Q38296078 | ||
| Does bacteriology laboratory automation reduce time to results and increase quality management? | Q38636008 | ||
| Impact of a Carbapenem Antimicrobial Stewardship Program on Patient Outcomes | Q38674798 | ||
| Hydrolytic mechanism of OXA-58 enzyme, a carbapenem-hydrolyzing class D β-lactamase from Acinetobacter baumannii | Q38795412 | ||
| Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine | Q38953322 | ||
| The automated clinical microbiology laboratory: fact or fantasy? | Q39227127 | ||
| Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship Programs | Q39274504 | ||
| Changing epidemiology and management of infectious diseases in US EDs. | Q39866903 | ||
| Semi-quantitative MALDI-TOF for antimicrobial susceptibility testing in Staphylococcus aureus. | Q40072562 | ||
| Multicentre evaluation of the BYG Carba v2.0 test, a simplified electrochemical assay for the rapid laboratory detection of carbapenemase-producing Enterobacteriaceae | Q40073893 | ||
| LC-MS/MS: a rapid and simple new method for the determination of carbapenem β-lactamases | Q40281978 | ||
| Comparison of the Novel Oxa-48 and Kpc K-SeT Assay, and Blue-Carba Test for the Detection of Carbapenemase-Producing Enterobacteriaceae Using PCR as a Reference Method | Q40303891 | ||
| High Prevalence and Predominance of the aph(2″)-If Gene Conferring Aminoglycoside Resistance in Campylobacter | Q40305869 | ||
| Comparative Evaluation of Four Phenotypic Tests for Detection of Carbapenemase-Producing Gram-Negative Bacteria | Q40419628 | ||
| Performance of the BD MAX™ instrument with Check-Direct CPE real-time PCR for the detection of carbapenemase genes from rectal swabs, in a setting with endemic dissemination of carbapenemase-producing Enterobacteriaceae | Q40636520 | ||
| Simultaneous Identification of Multiple β-Lactamases in Acinetobacter baumannii in Relation to Carbapenem and Ceftazidime Resistance, Using Liquid Chromatography-Tandem Mass Spectrometry | Q40673302 | ||
| Multicentre evaluation of a real-time PCR assay to detect genes encoding clinically relevant carbapenemases in cultured bacteria | Q40823002 | ||
| A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. | Q40832403 | ||
| Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain. | Q40891458 | ||
| Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae | Q40894875 | ||
| Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae | Q40954659 | ||
| Rapid Detection of Polymyxin-Resistant Enterobacteriaceae from Blood Cultures | Q40979248 | ||
| Evaluation of the RAPIDEC® CARBA NP, the Rapid CARB Screen® and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae | Q41060492 | ||
| MALDI-TOF MS detection of carbapenemase activity in clinical isolates of Enterobacteriaceae spp., Pseudomonas aeruginosa, and Acinetobacter baumannii compared against the Carba-NP assay | Q41508617 | ||
| Bacterial resistance to aminoglycoside antibiotics | Q41522159 | ||
| Rapid Aminoglycoside NP Test for Rapid Detection of Multiple Aminoglycoside Resistance in Enterobacteriaceae | Q41646813 | ||
| Detection of carbapenemase-producing bacteria by using an ultra-performance liquid chromatography-tandem mass spectrometry method | Q41785966 | ||
| Rapid and simple determination of ciprofloxacin resistance in clinical strains of Escherichia coli | Q41835144 | ||
| Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF. | Q42104058 | ||
| An Improved In-house MALDI-TOF MS Protocol for Direct Cost-Effective Identification of Pathogens from Blood Cultures | Q42369161 | ||
| Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil | Q42390718 | ||
| Tn4401 carrying blaKPC is inserted within another insertion in pKpQIL and related plasmids | Q43126131 | ||
| Changes in aac(6')-Ib-cr prevalence and fluoroquinolone resistance in nosocomial isolates of Escherichia coli collected from 1991 through 2005. | Q43169864 | ||
| Detection of OmpK36 porin loss in Klebsiella spp. by matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q43195412 | ||
| Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. | Q44266033 | ||
| Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6')-Ib. | Q44432624 | ||
| Multicenter evaluation of the Xpert MRSA NxG Assay for detection of methicillin resistant Staphylococcus aureus in nasal swabs | Q46585347 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Validation of a novel automatic deposition of bacteria and yeasts on MALDI target for MALDI-TOF MS-based identification using MALDI Colonyst robot | Q47234065 | ||
| Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey | Q48083543 | ||
| Direct identification of clinical pathogens from liquid culture media by MALDI-TOF MS analysis | Q48090949 | ||
| OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories | Q48183219 | ||
| Automation in UK clinical biochemistry | Q48254567 | ||
| An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia. | Q49662593 | ||
| Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay | Q50099636 | ||
| Application of the MALDI Biotyper to clinical microbiology: progress and potential | Q50144495 | ||
| Prevalence of antimicrobial resistance and the cfiA resistance gene in Danish Bacteroides fragilis group isolates since 1973. | Q50551619 | ||
| Towards the early detection of β-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis. | Q50700084 | ||
| Rapid direct detection of carbapenemase-producing Enterobacteriaceae in clinical urine samples by MALDI-TOF MS analysis. | Q50934278 | ||
| Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae by MALDI-TOF MS analysis. | Q50963299 | ||
| Comparison of imipenem and meropenem antibiotics for the MALDI-TOF MS detection of carbapenemase activity. | Q51066409 | ||
| Phenotypic detection of the cfiA metallo-β-lactamase in Bacteroides fragilis with the meropenem-EDTA double-ended Etest and the ROSCO KPC/MBL Confirm Kit. | Q51115410 | ||
| Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC in conferring carbapenem resistance among non-producing carbapenemase-Klebsiella pneumoniae. | Q52690727 | ||
| Analysis of Escherichia coli STs and resistance mechanisms in sewage from Islamabad, Pakistan indicates a difference in E. coli carriage types between South Asia and Europe. | Q53279533 | ||
| Detection of carbapenemase activity using VITEK MS: interplay of carbapenemase type and period of incubation. | Q53378075 | ||
| Prospective evaluation of the OKN K-SeT assay, a new multiplex immunochromatographic test for the rapid detection of OXA-48-like, KPC and NDM carbapenemases. | Q53384785 | ||
| Quantitative and automated MALDI-TOF MS-based detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae. | Q53720579 | ||
| Complete Genome Sequence of a Streptococcus pyogenes Serotype M12 Scarlet Fever Outbreak Isolate from China, Compiled Using Oxford Nanopore and Illumina Sequencing. | Q55091697 | ||
| An Automated Sample Preparation Instrument to Accelerate Positive Blood Cultures Microbial Identification by MALDI-TOF Mass Spectrometry (Vitek®MS). | Q55262380 | ||
| MALDI-TOF for the rapid detection of carbapenemase-producing Enterobacteriaceae: comparison of the commercialized MBT STAR®-Carba IVD Kit with two in-house MALDI-TOF techniques and the RAPIDEC® CARBA NP | Q59275378 | ||
| Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers | Q85962587 | ||
| Automation in clinical microbiology | Q86441251 | ||
| Methicillin-resistant Staphylococcus aureus | Q88924840 | ||
| Evaluation of two commercial carbapenemase gene assays, the Rapidec Carba NP test and the in-house Rapid Carba NP test, on bacterial cultures | Q89105730 | ||
| P433 | issue | 1 | |
| P577 | publication date | 2018-11-28 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for the Rapid Detection of Antimicrobial Resistance Mechanisms and Beyond | |
| P478 | volume | 32 |
| Q92071680 | Accurate Detection of the Four Most Prevalent Carbapenemases in E. coli and K. pneumoniae by High-Resolution Mass Spectrometry |
| Q93051863 | Editorial: MALDI-TOF MS Application in Microbial Ecology Studies |
| Q92071476 | One System for All: Is Mass Spectrometry a Future Alternative for Conventional Antibiotic Susceptibility Testing? |
| Q92037634 | Overestimated discriminatory power of MALDI-TOF mass spectrometry for typing of carbapenem-resistant Klebsiella pneumoniae clones |
| Q91687918 | Performance Evaluation of the MBT STAR®-Carba IVD Assay for the Detection of Carbapenemases With MALDI-TOF MS |
| Q90411073 | Rapid Detection of KPC-Producing Enterobacterales Susceptible to Imipenem/Relebactam by Using the MALDI-TOF MS MBT STAR-Carba IVD Assay |
| Q97905372 | Rapid antibiotic susceptibility testing of bacteria from patients' blood via assaying bacterial metabolic response with surface-enhanced Raman spectroscopy |
| Q91934323 | Screening of biomarkers of drug resistance or virulence in ESCAPE pathogens by MALDI-TOF mass spectrometry |
| Q90002513 | The path of biomolecular mass spectrometry into open research |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.